Want to see ABCL full AI Analyst Report?
ETFs with AbCellera Biologics (ABCL) Exposure
The following ETFs maintain exposure to AbCellera Biologics (ABCL). ETF holdings data are updated once a day, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
18 ETFs Hold AbCellera Biologics (ABCL)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in ABCL |
|---|---|---|---|---|---|---|
| XDNA | iShares Genomics Immunology and Healthcare Index ETF Trust Units | $21.79M | 0.52% | 2.62% | $570.76K | <0.01% |
| IDNA | iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | $337.92M | 0.47% | 2.49% | $8.32M | 0.21% |
| NIFE | ― | ― | ― | 2.03% | $46.06K | <0.01% |
| BBC | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | 1.82% | $625.72K | 0.02% |
| FDT | First Trust Developed Markets ex-US AlphaDEX Fund | $1.37B | 0.80% | 0.39% | $5.31M | 0.13% |
| OM3E | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | 0.27% | $3.60M | 0.08% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | 0.25% | $305.23K | <0.01% |
| ACSG | American Century Small Cap Growth Insights ETF | $54.55M | 0.49% | 0.21% | $117.16K | <0.01% |
| IBB | iShares Biotechnology ETF | $11.52B | 0.44% | 0.21% | $23.89M | 0.60% |
| PDN | Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF | $345.95M | 0.47% | 0.11% | $366.79K | <0.01% |
| ZGEN | ― | ― | ― | 0.07% | $2,103.96 | <0.01% |
| SPDW | SPDR Portfolio Developed World ex-US ETF | $41.36B | 0.03% | 0.02% | $7.62M | 0.18% |
| AVSC | Avantis U.S Small Cap Equity ETF | $3.23B | 0.25% | 0.02% | $518.75K | 0.01% |
| ONEQ | Fidelity Nasdaq Composite Index ETF | $10.76B | 0.21% | 0.01% | $1.15M | 0.03% |
| AVUS | Avantis U.S. Equity ETF | $14.88B | 0.15% | <0.01% | $847.73K | 0.02% |
| GERD | L&G Gerd Kommer Multifactor Equity UCITS ETF AccumUSD | $1.68B | 0.45% | <0.01% | $107.79K | <0.01% |
| K0MR | L&G Gerd Kommer Multifactor Equity UCITS ETF USD | $276.76M | 0.45% | <0.01% | $107.79K | <0.01% |
| ZAUT | ― | ― | ― | <0.01% | $611.62 | <0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in ABCL |
|---|---|---|---|---|---|---|
| XDNA | 2.62% | iShares Genomics Immunology and Healthcare Index ETF Trust Units | $21.79M | 0.52% | $570.76K | <0.01% |
| IDNA | 2.49% | iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | $337.92M | 0.47% | $8.32M | 0.21% |
| NIFE | 2.03% | ― | ― | ― | $46.06K | <0.01% |
| BBC | 1.82% | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | $625.72K | 0.02% |
| FDT | 0.39% | First Trust Developed Markets ex-US AlphaDEX Fund | $1.37B | 0.80% | $5.31M | 0.13% |
| OM3E | 0.27% | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | $3.60M | 0.08% |
| IBBQ | 0.25% | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | $305.23K | <0.01% |
| ACSG | 0.21% | American Century Small Cap Growth Insights ETF | $54.55M | 0.49% | $117.16K | <0.01% |
| IBB | 0.21% | iShares Biotechnology ETF | $11.52B | 0.44% | $23.89M | 0.60% |
| PDN | 0.11% | Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF | $345.95M | 0.47% | $366.79K | <0.01% |
| ZGEN | 0.07% | ― | ― | ― | $2,103.96 | <0.01% |
| SPDW | 0.02% | SPDR Portfolio Developed World ex-US ETF | $41.36B | 0.03% | $7.62M | 0.18% |
| AVSC | 0.02% | Avantis U.S Small Cap Equity ETF | $3.23B | 0.25% | $518.75K | 0.01% |
| ONEQ | 0.01% | Fidelity Nasdaq Composite Index ETF | $10.76B | 0.21% | $1.15M | 0.03% |
| AVUS | <0.01% | Avantis U.S. Equity ETF | $14.88B | 0.15% | $847.73K | 0.02% |
| GERD | <0.01% | L&G Gerd Kommer Multifactor Equity UCITS ETF AccumUSD | $1.68B | 0.45% | $107.79K | <0.01% |
| K0MR | <0.01% | L&G Gerd Kommer Multifactor Equity UCITS ETF USD | $276.76M | 0.45% | $107.79K | <0.01% |
| ZAUT | <0.01% | ― | ― | ― | $611.62 | <0.01% |
Popular ETF Comparisons
ABCL ETF Exposure FAQ
What ETFs hold AbCellera Biologics stock?
AbCellera Biologics (ABCL) is currently held by 18 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to ABCL include iShares (IBB), iShares (IDNA) and First Trust (FDT).
Which ETF has the largest exposure to ABCL?
The ETF with the largest exposure to ABCL is iShares (IBB), with approximately $23.89M in market value exposure.
How much ABCL stock is held by ETFs?
ETFs currently hold approximately $43.15M worth of AbCellera Biologics (ABCL) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.